ScoreWhy is Jinhe Biotechnology Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 8.53% and Operating profit at 2.01% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 5.60% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 8.53% and Operating profit at 2.01% over the last 5 years
3
Flat results in Jun 25
- INTEREST(HY) At CNY 45 MM has Grown at 18.38%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jinhe Biotechnology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jinhe Biotechnology Co., Ltd.
28.39%
1.34
48.31%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.53%
EBIT Growth (5y)
2.01%
EBIT to Interest (avg)
2.82
Debt to EBITDA (avg)
4.17
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.49
Tax Ratio
17.54%
Dividend Payout Ratio
74.79%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.63%
ROE (avg)
5.60%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
1.78
EV to EBIT
28.71
EV to EBITDA
13.83
EV to Capital Employed
1.44
EV to Sales
2.23
PEG Ratio
0.66
Dividend Yield
1.89%
ROCE (Latest)
5.00%
ROE (Latest)
5.68%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend33What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 462.22 MM
PRE-TAX PROFIT(Q)
At CNY 100.03 MM has Grown at 272.72%
NET PROFIT(Q)
At CNY 86.81 MM has Grown at 227.06%
ROCE(HY)
Highest at 6.48%
INTEREST COVERAGE RATIO(Q)
Highest at 758.02
RAW MATERIAL COST(Y)
Fallen by -4.67% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.67%
NET SALES(Q)
At CNY 758.61 MM has Grown at 23.53%
OPERATING PROFIT(Q)
Highest at CNY 173.8 MM
OPERATING PROFIT MARGIN(Q)
Highest at 22.91 %
EPS(Q)
Highest at CNY 0.12
-6What is not working for the Company
INTEREST(HY)
At CNY 45 MM has Grown at 18.38%
Here's what is working for Jinhe Biotechnology Co., Ltd.
Pre-Tax Profit
At CNY 100.03 MM has Grown at 272.72%
over average net sales of the previous four periods of CNY 26.84 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 86.81 MM has Grown at 227.06%
over average net sales of the previous four periods of CNY 26.54 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 462.22 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Interest Coverage Ratio
Highest at 758.02
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
Highest at CNY 758.61 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 758.61 MM has Grown at 23.53%
over average net sales of the previous four periods of CNY 614.12 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 173.8 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 22.91 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 100.03 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 86.81 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.12
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 2.67%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -4.67% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jinhe Biotechnology Co., Ltd.
Interest
At CNY 45 MM has Grown at 18.38%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
